Rumors Were True – Again: Abbott Did Try To Pull Out Of Alere Deal

Alere confirmed analysts’ suspicions that Abbott Laboratories is reticent about its planned $5.8bn takeover of the embattled diagnostics company, but the deal appears to be back on track, for now.